Eating Away at the Joint

Home page Description: 
A study led by Dr. Mohit Kapoor reveals a new mechanism responsible for osteoarthritis
Posted On: February 27, 2015
Image Caption: 
In cells undergoing autophagy, specialized structures called autophagosomes (red in the microscope image above) use acids to break down unwanted cellular components.

Osteoarthritis (OA) is characterized by the erosion of joint cartilage (the tough elastic material that protects the ends of bones). This damage is caused by inflammation, which can lead to joint stiffness and swelling that can be debilitating. The mechanisms responsible for joint inflammation and cartilage destruction in OA are not fully known; however, a recent study led by TWRI Scientist, Dr. Mohit Kapoor, has revealed one of the processes responsible.

Using an experimental model of OA, Dr. Kapoor and his team discovered that PPARγ—a factor that governs genes that respond to inflammation and joint destruction—is critical to keep the disease under control. PPARγ promoted autophagy, a self-protective process in which debris are recycled within cells. When PPARγ function was lost, joint inflammation and cartilage destruction increased—two effects that when combined accelerated the progression and severity of OA.

This study suggests that therapeutics capable of promoting PPARγ function may be effective for OA. These anti-inflammatory drugs, known as PPARγ agonists, are already approved for treating diseases like diabetes. As such, they represent an accessible option for improving the quality of life of people with OA.

This work was supported by the Canadian Institutes of Health Research, the Canadian Arthritis Network/The Arthritis Society and the Toronto General & Western Hospital Foundation. Image modified from "Pan et al. Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation. PLoS One. 2012. 7(4):e35315".

PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Vasheghani F, Zhang Y, Li YH, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall WK, Rampersaud YR, Mahomed NN, Gandhi R, Pelletier JP, Martel-Pelletier J, Kapoor M. Annals of Rheumatic Disease. 2015 January 8. [Pubmed abstract]

Comments